Marquette Asset Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1395067
MINNEAPOLIS, MN
Position in VRTX
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$22,352
+$3,598 QoQ
Shares Held
45
+7.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,591
of 1,735 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Marquette Asset Management, LLC holds $1,528,077 across 29 Biotechnology names. VRTX ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCYC |
Bicycle Therapeutics PLC
|
72,854 | $308,900 | |
| 2 | ENGN |
enGene Therapeutics Inc.
|
150,546 | $260,444 | |
| 3 | NKTX |
Nkarta, Inc.
|
75,071 | $212,450 | |
| 4 | PLRX |
Pliant Therapeutics, Inc.
|
174,500 | $198,930 | |
| 5 | FULC |
Fulcrum Therapeutics, Inc.
|
38,552 | $141,100 | |
| 6 | ZNTL |
Zentalis Pharmaceuticals, Inc.
|
28,973 | $140,519 | |
| 7 | SEER |
Seer, Inc.
|
61,816 | $102,614 | |
| 8 | MGX |
Metagenomi Therapeutics, Inc.
|
72,121 | $85,823 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,352 | 45 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $18,754 | 42 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $19,041 | 42 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $12,532 | 32 | Shares | Sole | 2025-10-24 | |
| 2023-12-31 | $24,006 | 59 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $21,212 | 61 | Shares | Other | 2023-10-27 | |
| 2023-06-30 | $27,448 | 78 | Shares | Other | 2023-07-28 | |
| No filing history on record for this holder in this stock. | ||||||